7β-Hydroxycholesterol induces Ca2+ oscillations, MAP kinase activation and apoptosis in human aortic smooth muscle cells

Atherosclerosis

Volumn 153, Issue 1, 2000, Pages 23-35

  Ares, Mikko P S ^a   Porn Ares M Isabella ^b   Moses, Sara ^a   Thyberg, Johan ^c   Juntti Berggren, Lisa ^d   Berggren, Per Olof ^d   Hultgårdh Nilsson, Anna ^a   Kallin, Bengt ^d   Nilsson, Jan ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

7 Hydroxycholesterol; Ca2+ oscillations; MAP kinase activation

Indexed keywords

25 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; CALCIUM ION; CHOLESTEROL; CHOLESTEROL 5ALPHA,6ALPHA OXIDE; CYTOKINE; GAMMA INTERFERON; METHIONINE; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZED LOW DENSITY LIPOPROTEIN; SULFUR 35; THAPSIGARGIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VERAPAMIL; CALCIUM; CHOLEST 5 EN 3 BETA,7 ALPHA DIOL; CHOLEST-5-EN-3 BETA,7 ALPHA-DIOL; CHOLESTEROL DERIVATIVE; DNA; PROTEIN SYNTHESIS INHIBITOR;

AORTA; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYTOTOXICITY; DNA DEGRADATION; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; NICK END LABELING; OSCILLATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; CELL CULTURE; CELL SURVIVAL; CHROMATIN; CYTOLOGY; DRUG EFFECT; METABOLISM;

AORTA; APOPTOSIS; CALCIUM; CELL SURVIVAL; CELLS, CULTURED; CHROMATIN; DNA; ENZYME ACTIVATION; HUMANS; HYDROXYCHOLESTEROLS; MICROSCOPY, ELECTRON; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; PROTEIN SYNTHESIS INHIBITORS;

EID: 0033623265     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00380-4     Document Type: Article

References (54)

1. Why do plaques rupture?
2. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1β-converting enzyme
3. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model
4. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques
5. Cell death in human atherosclerotic plaques involves both oncosis and apoptosis
6. Immunolocalization of native antioxidant scavenger enzymes in early hypertensive and atherosclerotic arteries. Role of oxygen free radicals
7. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages
8. Lipids and oxidized lipids in human atherosclerotic lesions at different stages of development
9. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate
10. Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte- derived macrophages
11. Inhibitors of protein and RNA synthesis block the cytotoxic effects of oxygenated sterols
12. Angiotoxicity of oxygenated sterols and possible precursors
13. Cytotoxicity of cholesterol oxides and their effects on cholesterol metabolism in cultured human aortic smooth muscle cells
14. 2+ channel blockers verapamil and nifedipine inhibit apoptosis induced by 25-hydroxycholesterol in human aortic smooth muscle cells
15. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme
16. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis
17. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol
18. 7β-Hydroperoxycholest-5-en-3β-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein
19. In vivo oxidised cholesterol in atherosclerosis
20. 2+-ATPase inhibitor thapsigargin
21. 2+ channels exposed to serum from patients with type I diabetes
22. Role of calcium in the programmed death of rat prostatic glandular cells
23. T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis
24. Effect of glucocorticoid treatment on intracellular calcium homeostasis in mouse lymphoma cells
25. Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production
26. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
27. Bcl-2 protein inhibits bufalin-induced apoptosis through inhibition of mitogen-activated protein kinase activation in human leukemia U937 cells
28. The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells
29. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway
30. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis
31. Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-γ but not IL-2 and IL-4: the possible role for IL-6 and interferon-γ in vascular inflammation
32. 2+ in the pancreatic B-cell
33. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques
34. The smooth muscle cell in culture
35. The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin
36. Persistent intracellular calcium pool depletion by thapsigargin and its influence on cell growth
37. Maintenance of calcium homeostasis in the endoplasmic reticulum by Bcl-2
38. Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade
39. The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region
40. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
41. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity
42. Oxidized low-density lipoprotein induces transcription factor activator protein-1 but inhibits activation of nuclear factor-κB in human vascular smooth muscle cells
43. An essential role for NF-κB in preventing TNF-α-induced cell death
44. NF-κB inactivation converts a hepatocyte cell line TNF-α response from proliferation to apoptosis
45. Requirement of nitric oxide and calcium mobilization for the induction of apoptosis in adrenal vascular endothelial cells
46. Mechanisms of calcium-related cell death
47. The regulation of p42-p44 mitogen-activated protein kinases in the injured rat carotid artery
48. Identification of regulatory oxysterols, 24(S), 25-epoxycholesterol and 25-hydroxycholesterol, in cultured fibroblasts
49. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol biosynthesis by oxylanosterols
50. DNA and cholesterol biosynthesis in synchronized embryonic rat fibroblasts. I. Temporal relationships between HMG-CoA reductase activity, sterol biosynthesis and thymidine incorporation into DNA
51. Cytotoxicity of oxidized low-density lipoprotein to mouse peritoneal macrophages: an ultrastructural study
52. Fragmentation of DNA in P388D1 macrophages exposed to oxidized low-density lipoprotein
53. Oxidized LDL induces apoptosis in cultured smooth muscle cells: a possible role for 7-ketocholesterol
54. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts